
zzso zzso have emerged as a strategy for the development of cancer vaccines and gene therapy zzso The availability of a new packaging cell line zzso which is capable of generating zzso zzso particles without contamination from zzso virus, has advanced the field of vaccine zzso This zzso vaccine zzso has potential advantages over naked zzso acid vaccines, such as increased efficiency of gene delivery and large-scale zzso We have developed a new strategy to enhance zzso acid vaccine potency by linking zzso a zzso zzso virus type 1 zzso zzso zzso to a model zzso This strategy facilitated the spread of linked zzso zzso to neighboring zzso In this study, we created a zzso zzso virus zzso zzso particle zzso zzso linked to a model tumor zzso human zzso type 16 zzso zzso using a stable zzso zzso The linkage of zzso to zzso in these zzso zzso particles resulted in a significant increase in the number of zzso zzso T cell precursors and a strong zzso effect against zzso tumors in vaccinated zzso mice relative to zzso zzso zzso zzso zzso Furthermore, a head-to-head comparison of zzso naked DNA, naked zzso zzso or zzso zzso particle vaccines indicated that zzso zzso particles generated the most potent therapeutic zzso zzso Our results indicated that the zzso strategy used in the context of zzso zzso particles may facilitate the generation of a highly effective vaccine for widespread zzso 

